AQST
Aquestive Therapeutics
$4.99
−$0.16 (−3.11%)Sep 10, 2026
Key metrics
The numbers that frame AQST today
- Market cap
- $626.30M
- P/E (TTM)
- -8.0
- EV / FCF
- -14.7
- Gross margin
- 67%
- EV / Sales
- 12.5
- ROIC
- -44.3%
- Div yield
- 0%
- 52wk Low
- $2.93
- 52wk High
- $7.55
Growth
Revenue and earnings trend for AQST
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AQST
Is Aquestive Therapeutics a good buy?
No. Aquestive Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Aquestive Therapeutics is selling at a very high price.
What is the market capitalization of AQST?
Aquestive Therapeutics's market capitalization is $626.30M.
What is the P/E ratio for AQST stock?
Aquestive Therapeutics's current P/E ratio is -8.
What is the 52-week high for AQST stock?
The 52-week high for Aquestive Therapeutics is $7.55. The current close of $4.99 is 33.9% below that high.
What is the 52-week low for AQST stock?
The 52-week low for Aquestive Therapeutics is $2.93. The current close of $4.99 is 70.3% above that low.
Does AQST stock pay dividends?
Aquestive Therapeutics does not currently show a dividend per share in the company data.